×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
Yahoo Finance
Jaguar Health, Inc. ... Jaguar family company Napo Pharmaceuticals focuses on developing and commercializing human prescription pharmaceuticals...
2 weeks ago
Jaguar Health, Inc. | Nation and World | corsicanadailysun.com
Corsicana Daily Sun
Jaguar planning to begin commercial launch of FDA-approved Gelclair® prescription gel for oral mucositis (also called “chemo mouth”) in Q3...
5 days ago
What Is Going on With Jaguar Health (JAGX) Stock Today?
InvestorPlace
Jaguar Health (JAGX) is holding off on a potential reverse stock split. The company hopes a new study will help create a market for its...
2 weeks ago
Jaguar Health stock gains as reverse stock split cleared
Seeking Alpha
Jaguar Health (NASDAQ:JAGX) shares spiked on Wednesday after the antidiarrheal drug developer won shareholder approval to implement a...
2 weeks ago
Jaguar Health's Strategic Moves to Regain Nasdaq Compliance - TipRanks.com
Tipranks
Jaguar Animal Health (JAGX) has issued an announcement. Jaguar Health, Inc. stockholders approved all four proposals during a special...
2 weeks ago
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in ...
AccessWire
Jaguar planning to begin commercial launch of FDA-approved Gelclair® prescription gel for oral mucositis (also called "chemo mouth") in Q3...
5 days ago
Jaguar Health, Inc. | Bay Area | smdailyjournal.com
San Mateo Daily Journal
Jaguar planning to begin commercial launch of FDA-approved Gelclair® prescription gel for oral mucositis (also called “chemo mouth”) in Q3 2024 Company to...
5 days ago
Jaguar Health balances ambitions for human and animal pharmaceuticals
Pharmaceutical Technology
After having completed a Phase III registrational trial investigating its treatment for diarrhoea related to cancer care called Mytesi (...
1 month ago
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in ...
Chronicle-Tribune
Jaguar planning to begin commercial launch of FDA-approved Gelclair® prescription gel for oral mucositis (also called “chemo...
5 days ago
Jaguar Health, Inc. (NASDAQ:JAGX) Shares Fly 55% But Investors Aren't Buying For Growth
Simply Wall Street
Jaguar Health, Inc. ( NASDAQ:JAGX ) shareholders are no doubt pleased to see that the share price has bounced 55% in...
1 month ago